Treatment of Anemia - Biotech, Pharma and Life Science Channel
PubMed Articles
Interstitial lung disease associated with lung cancer treatment.
Interstitial lung disease is one of the most serious side effects caused by lung cancer treatment. Due to the complexity diagnosis and variability of the disease, it is often not diagnosied and treate...
No one treatment is likely to affect all patients with a disorder in the same way. A treatment highly effective for some may be ineffective or even harmful for others. Statistically significant or not...
In their paper " The importance of (18)F-FDG PET/CT, CT and X-rays in detecting primary stage IIIA lung cancer and the incidence of extra thoracic metastases" published in Hell J Nucl Med, Sharma et a...
Opening and blocking the inner-pores of halloysite.
Aggregation and dispersion behaviours of halloysite nanotubes (HNTs) were influenced by pH. The meso- and micro-porosity of halloysite were determined by N2 gas physisorption. The blocking and opening...
Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options.
Patients chronically infected with hepatitis C virus (HCV) genotype 2 or 3 for whom treatment with peginterferon is not an option, or who have not had a response to prior interferon treatment, current...
Severe autoimmune hemolytic anemia with renal neoplasm.
Autoimmune hemolytic anemia is a type of hemolytic anemia characterized by autoantibodies directed against red blood cells shortening their survival. When autoimmune hemolytic anemia is secondary to a...
Cancer treatment is complicated because of a multitude of treatment options and little patient-specific information to help clinicians choose appropriate therapy. There are two genomes relevant in can...
ABSTRACT Background: The Charles Bonnet syndrome (CBS) is characterized by distinct visual hallucinations and ocularpathology causing visual impairment in patients with insight and the absence of psyc...
Generalized Alopecia with Vasculitis-Like Changes in a Dog with Babesiosis.
A locally bred, 12-year-old, intact female Satsuma dog presented with generalized alopecia. Erythema, crusts and desquamation were observed primarily on the truck. Papules and erosions were present in...
Peginesatide as a new approach for treating anemia of CKD patient: is it like a falling star?
Any scientific innovation needs to translate into a significant benefit. Peginesatide is noninferior to other erythropoiesis stimulating agents (ESAs) in terms of efficacy, and it shares the advantage...
News Articles
A1-PI treatment slows progression of emphysema in patients with AATD
Treatment with an Alpha-1 proteinase inhibitor (A1-PI), a naturally occurring protein that protects lung tissue from breakdown and protects the lung's elasticity, is effective in slowing the progressi...
Antidepressant treatment results in lower rate of MSIMI
Among patients with stable coronary heart disease and mental stress-induced myocardial ischemia (MSIMI), 6 weeks of treatment with the antidepressant escitalopram, compared with placebo, resulted in a...
AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing
Destination Hearing has joined the AudioNotch Tinnitus Treatment Clinic Partnership Program Toronto, Ontario (PRWEB) May 22, 2013 AudioNotch is the leading provider of advanced sound therapy for tinn...
10 Warning Signs: What Your Mouth Says About Your Health
NEW YORK, May 22, 2013 /PRNewswire/ -- If the eyes are the windows to your soul, then your mouth is the gateway to your overall health. Research has found a surprising number of links betwe...
Mari's to Offer New Treatment from Europe
Dallas, TX (PRWEB) May 22, 2013 Mariâs Skin Care, a peaceful sanctuary for skin rejuvenation and nourishment in Dallas, has become the first in the state of Texas to offer a new treatment from...
Nab-paclitaxel was well tolerated in this population of patients with pretreated advanced urothelial cancer with an encouraging tumour response. These results warrant further study of nab-paclitaxel i...
Amag investigates anemia drug after report of death in Switzerland
(Reuters) - Amag Pharmaceuticals Inc said its marketing partner in Switzerland, Takeda Pharmaceutical Co Ltd, is recalling a batch of Amag's anemia drug, Rienso, because of a death and several cases o...
CORRECTED-Amag investigates anemia drug after report of death in Switzerland
(Corrects headline to "investigates." Amag did not say the drug caused the fatality.)
Intermittent Zelboraf Treatment in Patients with Melanoma May Prevent Resistance to the Drug
Tumors resistant to Zelboraf® (vemurafenib) in patients with melanoma showed reduced growth after treatment was stopped. What’s more—animal models have shown that drug resistance was prevented by...
Novel Medicine For The Treatment Of Chronic Wounds
Every 20 seconds, a limb is lost as a consequence of diabetic foot ulcer that does not heal. To date, medical solutions that can change this situation are very limited. In his doctoral thesis Yue Shen...
Events
Webinar - Oncology Clinical Trials in Eastern Europe
Main focus on Breast cancer, Prostate cancer, Ovarian cancer, Lung cancer, Colorectal cancer
Companies
Merz North America is a specialty healthcare company that develops and commercializes innovative treatment solutions in aesthetics, dermatology and neurology in the U.S. and Canad...
Aradigm Corporation and Grifols S.A.
Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of sever...
Ignyta, Inc., located in San Diego, California, is a personalized medicine company developing revolutionary new products and services to customize diagnosis and treatment of patie...
Foundation Medicine is dedicated to the development of comprehensive tests that will help physicians personalize cancer treatment for their patients. Foundation Medicineâs la...
Eutropics Pharmaceuticals Inc.
Eutropics is addressing the need for improving the treatment of aggressive forms of leukemia, myeloma, lymphoma, and other cancers. The company is developing a novel diagnostic te...
Devon Medical, Inc. (www.devonmedicalproducts.com) is an ISO 13485 certified medical device manufacturer, designer, and distributor. Since 2005, we have developed innovative and h...
Scientific excellence that achieves new standards of care drives the company's work. 17 products are currently in clinical development addressing a variety of key medical needs.With patients in more t...
GL Rapha have been developing various ranges of pharmaceutical technologies specially focusing on Bio-pharmaceuticals such as recombinant proteins, synthetic peptides, and DDS bio similar based on t...
Founded in 1990, U.S. Physical Therapy, Inc. (NASDAQ:USPH) operates 369 clinics in 43 states. The Company's clinics provide preventative and post-operative care for a variety of o...
Columbia Laboratories, Inc. is focused on developing products that utilize its novel bioadhesive drug delivery technologies to optimize drug delivery in a controlled, sustained ma...
Clinical Trials
This prospective, multi-center, non-interventional study will evaluate the efficacy and safety of Herceptin (trastuzumab) in routine clinical practice in Chinese patients with gastric or g...
This study will evaluate the safety and effectiveness of treating patients with severe aplastic anemia (SAA) or myelopdysplastic syndrome (MDS) with both peripheral blood stem cells from a...
This is a prospective, multi-center, randomized, placebo-controlled trial in subjects with histological evidence of > 33% hepatic steatosis or nonalcoholic steatohepatitis (NASH) and chron...
Effects of Anemia Correction on Vascular and Monocyte Function in Renal Transplant Recipients
Correction of anaemia in renal transplant recipients by parenteral application of recombinant erythropoietin and if necessary iron will improve large artery function (endothelial function...
Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization
Problems of compatibility between a mother and her child are frequent. The most well-known case can be illustrated by the fetomaternal blood group incompatibility (rhesus factor) which can...
Alemtuzumab to Treat Severe Aplastic Anemia
This study will evaluate the safety and usefulness of a new immunosuppressive drug, alemtuzumab (Campath(Registered Trademark)), in patients with severe aplastic anemia (SAA). SAA is a rar...
Phase 2 Study Of Neoadjuvant Iressa Treatment In Stage 1 NSCLC
ELIGIBILITY - Non-small cell lung cancer Clinical Stage 1A (T1N0M0 a tumor that is 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, and without bronchosc...
Nicotinic Acid - Pharmacokinetics, Pharmacodynamics, Receptor Expression
The study will be a double-blind, randomized, placebo-controlled, single-center, 2 treatment, 3-way crossover. Subjects will be randomly allocated to a treatment sequence – AAB, ABA or...
Genetics of Alpha Thalassemia in Israeli Ethnic Groups
Alpha thalassemia causes mild anemia and is found in many ethnic groups. Usually it is found in regions where malaria is endemic. We have found that alpha thalassemia is common in Ashkenaz...
This is a multi-center open label, randomized phase-3 study with stratification according to diagnosis and baseline serum-EPO level. The correction of mild or moderate anemia and the effec...
Videos
Anemia symptoms and treatments - Signs of being anemic
http://www.howdini.com/howdini-video-6638391.html Anemia symptoms and treatments - Signs of being anemic Many women suffer from anemia, which can be serious ...
Medical and Biotech [MESH] Definitions
Consent Forms
Documents describing a medical treatment or research project, including proposed procedures, risks, and alternatives, that are to be signed by an individual, or the individual's proxy, to indicate his/her understanding of the document and a willingness to undergo the treatment or to participate in the research.
Duty To Recontact
The ethical and/or legal obligation of a health provider or researcher to communicate with a former patient or research subject about advances in research relevant to a treatment or to a genetic or other diagnostic test provided earlier, or about proposed new uses of blood or tissue samples taken in the past for another purpose.
Genetic Services
Organized services to provide diagnosis, treatment, and prevention of genetic disorders.
Rare Diseases
A large group of diseases which are characterized by a low prevalence in the population. They frequently are associated with problems in diagnosis and treatment.
Virus Inactivation
Inactivation of viruses by non-immune related techniques. They include extremes of pH, HEAT treatment, ultraviolet radiation, IONIZING RADIATION; DESICCATION; ANTISEPTICS; DISINFECTANTS; organic solvents, and DETERGENTS.
